BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22870188)

  • 1. Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Aβ or tau pathology.
    Castello NA; Green KN; LaFerla FM
    PLoS One; 2012; 7(8):e39566. PubMed ID: 22870188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
    Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
    Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice.
    Kapadia M; Mian MF; Michalski B; Azam AB; Ma D; Salwierz P; Christopher A; Rosa E; Zovkic IB; Forsythe P; Fahnestock M; Sakic B
    J Alzheimers Dis; 2018; 63(3):1191-1205. PubMed ID: 29710702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits.
    Gerenu G; Martisova E; Ferrero H; Carracedo M; Rantamäki T; Ramirez MJ; Gil-Bea FJ
    Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):991-1001. PubMed ID: 28132883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice.
    Baglietto-Vargas D; Chen Y; Suh D; Ager RR; Rodriguez-Ortiz CJ; Medeiros R; Myczek K; Green KN; Baram TZ; LaFerla FM
    J Neurochem; 2015 Sep; 134(5):915-26. PubMed ID: 26077803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction.
    Corona C; Masciopinto F; Silvestri E; Viscovo AD; Lattanzio R; Sorda RL; Ciavardelli D; Goglia F; Piantelli M; Canzoniero LM; Sensi SL
    Cell Death Dis; 2010 Oct; 1(10):e91. PubMed ID: 21368864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockout of 5-lipoxygenase prevents dexamethasone-induced tau pathology in 3xTg mice.
    Joshi YB; Chu J; Praticò D
    Aging Cell; 2013 Aug; 12(4):706-11. PubMed ID: 23634895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble aβ promotes wild-type tau pathology in vivo.
    Chabrier MA; Blurton-Jones M; Agazaryan AA; Nerhus JL; Martinez-Coria H; LaFerla FM
    J Neurosci; 2012 Nov; 32(48):17345-50. PubMed ID: 23197725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fyn knock-down increases Aβ, decreases phospho-tau, and worsens spatial learning in 3×Tg-AD mice.
    Minami SS; Clifford TG; Hoe HS; Matsuoka Y; Rebeck GW
    Neurobiol Aging; 2012 Apr; 33(4):825.e15-24. PubMed ID: 21741124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.
    Winton MJ; Lee EB; Sun E; Wong MM; Leight S; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2011 May; 31(21):7691-9. PubMed ID: 21613482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.
    Hirata-Fukae C; Li HF; Hoe HS; Gray AJ; Minami SS; Hamada K; Niikura T; Hua F; Tsukagoshi-Nagai H; Horikoshi-Sakuraba Y; Mughal M; Rebeck GW; LaFerla FM; Mattson MP; Iwata N; Saido TC; Klein WL; Duff KE; Aisen PS; Matsuoka Y
    Brain Res; 2008 Jun; 1216():92-103. PubMed ID: 18486110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Levels of Brain-Derived Neurotrophic Factor Trigger Self-aggregated Amyloid β-Induced Neuronal Cell Death in an Alzheimer's Cell Model.
    Tagai N; Tanaka A; Sato A; Uchiumi F; Tanuma SI
    Biol Pharm Bull; 2020; 43(7):1073-1080. PubMed ID: 32612070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential.
    Gao L; Zhang Y; Sterling K; Song W
    Transl Neurodegener; 2022 Jan; 11(1):4. PubMed ID: 35090576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.
    Song MS; Learman CR; Ahn KC; Baker GB; Kippe J; Field EM; Dunbar GL
    Neuroscience; 2015 Oct; 307():37-50. PubMed ID: 26297896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived neurotrophic factor and TrkB expression in the "oldest-old," the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta.
    Michalski B; Corrada MM; Kawas CH; Fahnestock M
    Neurobiol Aging; 2015 Dec; 36(12):3130-3139. PubMed ID: 26410307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HDAC3 reverses Alzheimer's disease-related pathologies in vitro and in the 3xTg-AD mouse model.
    Janczura KJ; Volmar CH; Sartor GC; Rao SJ; Ricciardi NR; Lambert G; Brothers SP; Wahlestedt C
    Proc Natl Acad Sci U S A; 2018 Nov; 115(47):E11148-E11157. PubMed ID: 30397132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology.
    Oddo S; Caccamo A; Tran L; Lambert MP; Glabe CG; Klein WL; LaFerla FM
    J Biol Chem; 2006 Jan; 281(3):1599-604. PubMed ID: 16282321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.